Accelerate Diagnostics, Inc.
Accelerate Diagnostics, Inc. (AXDX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AXDX · as of Jun 9, 2026
Key Statistics
Explore Accelerate Diagnostics, Inc. Data
axdx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 25.0%
Competitors & Peers
axdx competitorsAXDX
ACOR
BIOL
BLCM
CYTH
HTGMQStock Performance
Full HistoryAbout Accelerate Diagnostics, Inc.
Accelerate Diagnostics, Inc. is an in vitro diagnostics company specializing in solutions for the rapid diagnosis of critical infections, with operations spanning the United States, Europe, and the Mi…
what is accelerate diagnostics, inc. · axdx stock overview · accelerate diagnostics, inc. company profile · who is accelerate diagnostics, inc. ceo · axdx NASDAQ · accelerate diagnostics, inc. headquarters · accelerate diagnostics, inc. business segments
About Stock Overview & Key Data
Accelerate Diagnostics, Inc. (AXDX) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Apr 7, 1994. As of the latest trading session, AXDX stock price is $0.03, with a market capitalization of $859,918. The stock has returned -97.46% over the past 12 months and -97.30% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Accelerate Diagnostics, Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2024, Accelerate Diagnostics, Inc. reported revenue of $11.7M and net income of -$50.0M. For detailed data — including Accelerate Diagnostics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Accelerate Diagnostics, Inc. (AXDX) stock price is $0.03. The stock is traded on NASDAQ under the ticker symbol AXDX. The 52-week range is $0.01 – $2.09.